Pe 14 octombrie, 2026 Chișinăul va sărbători 590 de ani de la fondare. Vă dați seama: aproape șase secole are orașul nostru iubit. Drumul ...

Moderna remains a Sell as regulatory setbacks, notably the FDA's Refusal-to-File for mRNA-1010, highlight persistent execution and approval risks. The RTF for mRNA-1010 delays potential influenza ...

A few years ago, investors rushed to buy Moderna (NASDAQ: MRNA) stock. The biotech company had brought its coronavirus vaccine to market in less than a year and quickly saw earnings take off. The ...

CEO Stéphane Bancel reported that 2025 revenues were $1.9 billion, primarily from COVID vaccine sales, and highlighted a $2.2 billion reduction in operating expenses, stating "I would like to thank ...

Moderna is working to build a seasonal vaccines portfolio to spur growth. The FDA this week said it won’t review the biotech’s flu vaccine candidate. 10 stocks we like better than Moderna › A few ...

The US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 bear market, as the Massachusetts firm announced the first patient had been tested with its ...

A federal judge in Delaware has thrown out two key defenses Moderna (MRNA) had been claiming in its ongoing patent litigation with Arbutus Biopharma (ABUS) regarding its mRNA COVID-19 vaccine. Judge ...

Investigators are digging deep into code, doorbell video, and artificial intelligence in the search for Nancy Guthrie. In this report, we break down how AI can analyze more than just a suspect’s face, ...

Arbutus Biopharma ( (ABUS)) has provided an announcement. On February 2, 2026, the U.S. District Court for the District of Delaware issued a memorandum and order in the patent infringement litigation ...

Un proiect imobiliar ce vizează construirea a peste 20 de blocuri cu regim mare de înălțime, pe terenul fostei Fabrici de Zahăr, este contestat de locuitorii din zonă, care consideră că dezvoltarea ...